IL129482A0 - Method of enhancing the delivery of growth factors - Google Patents
Method of enhancing the delivery of growth factorsInfo
- Publication number
- IL129482A0 IL129482A0 IL12948297A IL12948297A IL129482A0 IL 129482 A0 IL129482 A0 IL 129482A0 IL 12948297 A IL12948297 A IL 12948297A IL 12948297 A IL12948297 A IL 12948297A IL 129482 A0 IL129482 A0 IL 129482A0
- Authority
- IL
- Israel
- Prior art keywords
- enhancing
- delivery
- growth factors
- diffusion
- enhanced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2856696P | 1996-10-16 | 1996-10-16 | |
PCT/US1997/014536 WO1998016242A1 (en) | 1996-10-16 | 1997-08-19 | Method of enhancing the delivery of growth factors |
Publications (1)
Publication Number | Publication Date |
---|---|
IL129482A0 true IL129482A0 (en) | 2000-02-29 |
Family
ID=21844162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12948297A IL129482A0 (en) | 1996-10-16 | 1997-08-19 | Method of enhancing the delivery of growth factors |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0938333B1 (xx) |
JP (1) | JP2001502323A (xx) |
AT (1) | ATE258804T1 (xx) |
AU (1) | AU733394B2 (xx) |
CA (1) | CA2269075A1 (xx) |
DE (1) | DE69727491T2 (xx) |
IL (1) | IL129482A0 (xx) |
WO (1) | WO1998016242A1 (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9913457A (pt) * | 1998-09-03 | 2001-10-16 | Neuronz Ltd | Neuroproteção |
FR2793684B1 (fr) * | 1999-05-17 | 2001-08-10 | Ethypharm Lab Prod Ethiques | Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant |
US7112570B2 (en) | 2000-08-24 | 2006-09-26 | Neuren Pharmaceuticals, Ltd. | GPE analogs |
GB0303362D0 (en) * | 2003-02-13 | 2003-03-19 | Enact Pharma Plc | Tissue regeneration |
GB2547179A (en) * | 2015-10-26 | 2017-08-16 | Quethera Ltd | Genetic construct |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8804164A0 (sv) * | 1988-11-17 | 1990-05-18 | Per Prisell | Farmaceutisk beredning |
WO1993009798A1 (en) * | 1991-11-12 | 1993-05-27 | Regeneron Pharmaceuticals, Inc. | Therapeutic and diagnostic methods based on tissue specific nt-3 expression and receptor binding |
CA2157785A1 (en) * | 1993-03-19 | 1994-09-29 | Immunex Corporation | Pharmaceutical compositions comprising soluble interleukin-4 receptor and interleukin-4 |
-
1997
- 1997-08-19 CA CA002269075A patent/CA2269075A1/en not_active Abandoned
- 1997-08-19 AT AT97938406T patent/ATE258804T1/de active
- 1997-08-19 AU AU40737/97A patent/AU733394B2/en not_active Ceased
- 1997-08-19 DE DE69727491T patent/DE69727491T2/de not_active Expired - Lifetime
- 1997-08-19 WO PCT/US1997/014536 patent/WO1998016242A1/en active IP Right Grant
- 1997-08-19 EP EP97938406A patent/EP0938333B1/en not_active Expired - Lifetime
- 1997-08-19 JP JP10518321A patent/JP2001502323A/ja active Pending
- 1997-08-19 IL IL12948297A patent/IL129482A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ATE258804T1 (de) | 2004-02-15 |
AU4073797A (en) | 1998-05-11 |
CA2269075A1 (en) | 1998-04-23 |
EP0938333B1 (en) | 2004-02-04 |
DE69727491T2 (de) | 2004-12-02 |
JP2001502323A (ja) | 2001-02-20 |
AU733394B2 (en) | 2001-05-10 |
EP0938333A1 (en) | 1999-09-01 |
WO1998016242A1 (en) | 1998-04-23 |
DE69727491D1 (de) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1264604A3 (en) | Improvements in or relating to contrast agents | |
ZA975851B (en) | Hepatocyte grown factor receptor agonists and uses thereof | |
ATE197549T1 (de) | Methoden zur regulation der den magen und darm betreffenden motilitaet | |
AU2693395A (en) | Glial mitogenic factors, their preparation and use | |
ATE208620T1 (de) | Kombinationspräparat zur anwendung bei immunologischen erkrankungen | |
ATE140483T1 (de) | Natürlicher killerzellen-stimulationsfaktor | |
GR3032673T3 (en) | Use of an effective quantitiy of active substances for the treatment of mixed skin. | |
EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
HUP9900654A3 (en) | Preparations stimulating nail growth, process for their preparation and use of them | |
ATE183774T1 (de) | Löslicher interferon-rezeptor, seine herstellung und anwendung | |
IL129482A0 (en) | Method of enhancing the delivery of growth factors | |
EE200000333A (et) | Eesnäärmevähi ravis kasutatav konjugaat ning farmatseutiline kompositsioon ja selle valmistamismeetod | |
WO1996015758A3 (en) | Methods for stimulating erythropoiesis using thrombopoietin | |
WO1990013643A3 (en) | Glycoprotein hormone receptor molecules | |
EE9800333A (et) | Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias | |
ES2183890T3 (es) | Uso del factor de crecimiento de hepatocitos para in estimular la proliferacion y diferenciacion de celulas hematopoyeticas. | |
DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
MXPA01006011A (es) | Composicion para tratamiento de quemaduras. | |
AU1939697A (en) | Physiologically active substances tkr1785's, process for the preparation thereof, and microbe | |
PL332035A1 (en) | Transdermal therapeutic system including an estriol-containing composition of active substances | |
EP0240366A3 (en) | Perhydrothiazepine and perhydroazepine derivatives, their preparation and their therapeutic use | |
UA28676A (uk) | Спосіб підготовки хворого до стоматологічного втручання | |
UA43374C2 (uk) | Спосіб виготовлення хірургічного шовного матеріалу | |
UA32551C2 (uk) | Спосіб утримання риб у несприятливих умовах | |
UA7187A (uk) | Спосіб лікування цукрового діабету |